Neuroendocrine host factors and inflammatory disease susceptibility

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 701-707

  Ligier, Sophie ^a   Sternberg, E M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Autoimmunity; Eosinophilia myalgia syndrome; Fischer rats; Hypothalamic pituitary adrenal axis; Lewis rats inflammation; Neuroendocrine system; Rheumatoid arthritis; Sjogren syndrome; Systemic lupus erythematosus

Indexed keywords

ENVIRONMENTAL CHEMICAL; TOXIC SUBSTANCE;

ADRENERGIC SYSTEM; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032703368     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5701     Document Type: Conference Paper

References (95)

1. Becker KG, Simon RM, Bailey-Wilson JE, Biddison WE, McFarland HF, Trent JM. Clustering of non-MHC susceptibility candidate loci in human autoimmune disease. Proc Natl Acad Sci 95:9979-9384 (1998).
2. Jarvinen P, Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum 24: 19-28 (1994).
3. Reveille JD. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10:187-200 (1998).
4. Sugar M. Arthritis and panhypopituitarism. J Clin Endocrinol Metab 13:1118-1121 (1953).
5. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. JAMA 267:1244-1252 (1992).
6. Sawchenko PE, Brown ER, Chan RK, Ericsson A, Li HY, Roland BL, Kovacs KJ. The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res 107:201-222 (1996).
7. Ehlert U, Straub R. Physiological and emotional response to psychological stressors in psychiatric and psychosomatic disorders. Ann NY Acad Sci 851:477-488 (1998).
8. Li HY, Ericsson A, Sawchenko PE. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 93:2359-2364 (1996)
9. Pacak K, Palkovits M, Yadid G, Kvetnansky R, Kopin IJ, Goldstein DS. Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am J Physiol 275:R1247-R1255 (1998).
10. Stenzel-Poore M, Vale WW, Rivier C. Relationship between antigen induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 132:1313-1318 (1993)
11. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology 130:1394-1400 (1992).
12. Makino S, Smith MA, Gold PW. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 136:3299-3309 (1995).
13. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 79:848-853 (1994).
14. Kanik KS, Hagiwara E, Yarboro CH, Schumacher HR, Wilder RL, Klinman DM. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol 25:16-22 (1998).
15. Shanks N, Harbuz MS, Jessop DS, Perks P, Moore PM, Lightman SL. Inflammatory disease as chronic stress. Ann NY Acad Sci 840:599-607 (1998).
16. Aguilera G, Jessop DS, Harbuz MS, Kiss A, Lightman SL. Differential regulation of hypothalamic pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat. J Endocrinol 153:185-191 (1997).
17. Harbuz MS, Conde GL, Marti O, Lightman SL, Jessop DS. The hypothalamic-pituitary-adrenal axis in autoimmunity. Ann NY Acad Sci 823:214-224 (1997).
18. Swain MG, Marie M. Prevention of immune-mediated arthritis in cholestatic rats: involvement of endogenous glucocorticoids. Gastroenterology 107:1469-1474 (1994).
19. Miller SC, Rapier SH, Holtsclaw LI, Turner BB. Effects of psychological stress on joint inflammation and adrenal function during induction of arthritis in the Lewis rat. Neuroimmunomodulation 2:329-338 (1995).
20. Sternberg EM. Neural-immune interactions in health and disease. J Clin Invest 100:2641-2647 (1997).
21. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med 117:854-866 (1992).
22. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362 (1995).
23. Brennan FM, Maini RN, Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull 51:368-384 (1995).
24. Banks WA, Kastin AJ. Relative contributions of peripheral and central sources to levels of IL-1α in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays. J Neuroimmunol 79:22-28 (1997).
25. Karanth S, Lyson K, McCann SM. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90:3383-3387 (1993).
26. Watkins LR, Goehler LE, Relton JK, Tartaglia N, Silbert L, Martin D, Maier SF. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 183:27-31 (1995).
27. Bluthe RM, Walter V, Parnet P, Laye S, Lestage J, Verrier D, Poole S, Stenning BE, Kelley KW, Dantzer R. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III 317:499-503 (1994).
28. McEwen BS, Biron C. A, Brunson KW. Bulloch K, Chambers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL, et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev 23:79-133 (1997).
29. DeRijk RH, Petrides J, Deuster P, Gold PW, Sternberg EM. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J Clin Endocrinol Metab 81:228-235 (1996).
30. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg, EM. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 β (IL-1β), IL-6, and tumor necrosis factor-α (TNFα) production in humans: high sensitivity of TNFα and resistance of IL-6. J Clin Endocrinol Metab 82:2182-91 (1997).
31. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 108:374-381 (1996).
32. Felten SY, Felten DL. Innervation of lymphoid tissue. In: Psychoneuroimmunology (Ader R, Feiten DL, Cohen N, eds). San Diego:Academic Press, 1991:27-61.
33. Madden KS, Moynihan JA, Brenner GJ, Feiten SY, Feiten DL, Livnat S. Sympathetic nervous system modulation of the immune system, III: Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol 49:77-87 (1994).
34. Madden KS, Fellen SY, Felten DL, Hardy CA, Livnat S. Sympathetic nervous system modulation of the immune system. II: Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J Neuroimmunol 49:67-75 (1994).
35. Madden KS, Thyagarajan S, Felten DL. Alterations in sympathetic noradrenergic innervation in lymphoid organs with age. Ann NY Acad Sci 840:262-268 (1998).
36. ThyagaRajan S, Felten SY, Felten DL. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of L-deprenyl treatment in young sympathectomized and old Fischer 344 rats. J Neuroimmunol 81:144-157 (1998).
37. Green PG, Janig W, Levine JD. Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci 17:3234-3238 (1997).
38. Green PG, Miao FJ, Strausbaugh H, Heller P, Janig W, Levine JD. Endocrine and vagal controls of sympathetically dependent neurogenic inflammation. Ann NY Acad Sci 840:282-288 (1998).
39. Goetzl EJ, Chernov T, Renold F, Payan DG. Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135:2(suppl):8025-8055 (1985).
40. Webster EL, Torpy DJ, Elenkov IJ, Chrousos GP. Corticotropin-releasing hormone and inflammation. Ann NY Acad Sci 640:21-32(1998).
41. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proe Natl Acad Sci USA 86:2374-2378 (1989).
42. Wilder RL, Allen JB, Hansen C. Thymus-dependent and -independent regulation of Ia antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis. Differences in site and intensity of expression in euthymic, athymic, and cyclosporin A-treated LEW and F344 rats. J Clin Invest 79:1160-1171 (1987).
43. Sternberg EM, Young WS III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 86:4771-4775 (1989).
44. MacPhee IAM, Antoni Ferenc A, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 169:431-445 (1989).
45. Flower RJ, Parente L, Persico P, Salmon JA. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br J Pharmacol 87:57-62 (1986).
46. Karalis K, Crofford L, Wilder RL, Chrousos GP. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology 136:3107-3112 (1995).
47. Misiewicz B, Zelazowska E, Raybourne RB, Cizza G, Sternberg EM. Inflammatory responses to carrageenan injection in LEW/N and F344/N rats: LEW/N rats show sex-and age-dependent changes in inflammatory reactions. Neuroimmunomodulation 3:93-101 (1996).
48. Misiewicz B, Poltorak M, Raybourne RB, Gomez M, Listwak S, Sternberg EM. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation. Exp Neurol 146:305-314 (1997).
49. Reder AT, Thapar M, Jensen MA. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 44:2289-2294 (1994).
50. Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 322:874-881 (1990).
51. Crofford LJ, Rader JI, Dalakas MC, Hill RH Jr, Page SW, Needham LL, Brady LS, Heyes MP, Wilder RL, Gold PW, Illa I, et al. L-Tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest 86:1757-1763 (1990).
52. Emslie-Smith AM, Mayeno AN, Nakano S, Gleich GJ, Engel AG, 1,1′-Ethylidenebis(tryptophan) induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome. Neurology 44:2390-2392 (1994).
53. Wilder RL, Remmers EF, Longman RE, Du Y, O'Hare A, Cannon GW, Griffiths MM. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet 14:82-85 (1996).
54. Listwak S, Barrientos RM, Koike G, Ghosh S, Gomez M, Misiewicz B, Sternberg EM. Identification of a novel inflammation-protective locus in the Fischer rat. Mamm Genome 10:362-365 (1999).
55. Lechner O, Hu Y, Jafarian-Tehrani M, Dietrich H, Schwarz S, Herold M, Haour F, Wick G. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav Immun 10:337-350 (1996).
56. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol Today 17:138-146 (1996).
57. 1 mouse model of systemic lupus erythematosus. Lupus 7:420-427 (1998).
58. Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, Schlechte JA. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann NY Acad Sci 840:762-772 (1998).
59. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 840:45-50 (1998).
60. Wick G, Sgonc R, Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann NY Acad Sci 840:591-538 (1998).
61. Fassler R, Dietrich H, Kromer G, Schwarz S, Brezinschek HP, Wick G. Diminished glucocorticoid tonus in obese strain (OS) chickens with spontaneous autoimmune thyroiditis: increased plasma levels of a physicochemically unaltered corticosteroid-binding globulin but normal total corticosterone plasma concentration and normal glucocorticoid receptor contents in lymphoid tissues. J Steroid Biochem 30:375-379 (1998).
62. Bagchi N, Brown TR, Urdanivia E, Sundick RS. Induction of autoimmune thyroiditis in chickens by dietary iodine. Science 230:325-327 (1985).
63. Van de Water J, Jimenez SA, Gershwin ME. Animal models of scleroderma: contrasts and comparisons, Int Rev Immunol 12:201-216 (1995).
64. Brezinschek HP, Gruschwitz M, Sgonc R, Moormann S, Herold M, Gershwin ME, Wick G. Effects of cytokine application on glucocorticoid secretion in an animal model for systemic scleroderma. J Autoimmun 6:719-733 (1993).
65. Herold M, Brezinschek HP, Gruschwitz M, Dietrich H, Wick G. Investigation of ACTH responses of chickens with autoimmune disease. Gen Comp Endocrinol 88:188-198 (1992).
66. Raskind MA, Peskind ER, Wilkinson CW. Hypothalamic-pituitary-adrenal axis regulation and human aging. Ann N Y Acad Sci 746:327-335 (1994).
67. Dorn LD, Burgess ES, Susman EJ, von Eye A, DeBellis MD, Gold PW, Chrousos GP. Response to oCRH in depressed and nondepressed adolescents: does gender make a difference? J Am Acad Child Adolesc Psychiatry 35:764-773 (1996).
68. Yanovski JA, Yanovski SZ, Harrington L, Gold PW, Chrousos GP. Differences in the hypothalamic-pituitary-adrenal axis of black and white men. Horm Res 44:208-212 (1995).
69. Adinoff B, Martin PR, Bone GH, Eckardt MJ, Roehrich L, George DT, Moss HB, Eskay R, Linnoila M, Gold PW. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry 47:325-330 (1990).
70. Abelson JL, Curtis GC. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels. Am J Psychiatry 153:69-73 (1996).
71. Pal SB. The secretion rate of cortisol in patients with rheumatoid arthritis. Clin Chim Acta 29:129-137 (1970)
72. Saldanha C, Tougas G, Grace E. Evidence for anti-inflammatory effect of normal circulating plasma cortisol. Clin Exp Rheumatol 4:365-366 (1986).
73. Harkness JA, Richter MB, Panayi GS, Van de Pette K, Linger A, Pownall R, Geddawi M. Circadian variation in disease activity in rheumatoid arthritis. Br Med J 284:551-554 (1982).
74. Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82:1279-1283(1997).
75. Hall J, Morand EF, Medbak S, Zaman M, Perry L, Goulding NJ, Maddison PJ, O'Hare JP. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum 37:1132-1137 (1994).
76. Templ E, Koeller M, Riedl M, Wagner O, Graninger W, Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 35:350-356 (1996).
77. Jorgensen C, Bressot N, Bologna C, Sany J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol 22:1829-1833 (1995).
78. Masi AT, Chrousos GP. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol 23:577-581 (1996).
79. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 35:1281-1288 (1992)
80. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 35:740-744 (1992).
81. Schlaghecke R, Beuscher D, Kornely E, Specker C. Effects of gluco-corticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum 37:1127-1131 (1994).
82. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group N Engl J Med 333:142-146 (1995).
83. Kavelaars A, de Jong-de Vos van Steenwijk T, Kuis W, Heijnen CJ. The reactivity of the cardiovascular system and immunomodulation by catecholamines in juvenile chronic arthritis. Ann NY Acad Sci 840:698-704 (1998).
84. Johnson EO. Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Hypofunction of the stress axis in Sjögren's syndrome J Rheumatol 25:1508-1514 (1998).
85. Gutierrez MA, Garcia ME, Rodriguez JA, Rivero S, Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus 7:404-408 (1998).
86. Vilarinho ST, Costallat LT. Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus. J Rheumatol 25:1097-1103 (1998).
87. Folomeev M, Dougados M, Beaune J, Kouyoumdjian JC, Nahoul K, Amor B, Alekberova Z. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1:191-195 (1992).
88. Davis DL, Axelrod D, Bailey L, Gaynor M, Sasco AJ. Rethinking breast cancer risk and the environment: the case for the precautionary principle. Environ Health Perspect 106:523-529 (1998).
89. Sakabe K, Yoshida T, Furuya H, Kayama F, Chan EK, Estrogenic xenobiotics increase expression of SS-A/Ro autoantigens in cultured human epidermal cells. Acta Derm Venereol 78:420-433 (1998).
90. Sakabe K, Onoe M, Yoshida T, Furuya H, Kayama F, Chan EK. Environmental estrogens increase expression of SS-A/Ro autoantigen in normal human epidermal keratinocytes. J Dermatol 25:558-550 (1998).
91. Reber PM. Prolactin and immunomodulation. Am J Med 95:637-644 (1993).
92. Rovensky J, Jurankova E, Rauova L, Blazickova S, Lukac J, Veselkova Z, Jezova D, Vigas M. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 24:2330-2334 (1997).
93. Neidhart M. Prolactin in autoimmune diseases. Proc Soc Exp Biol Med 217:408-419 (1998).
94. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Munoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 7:414-419 (1998).
95. McMurray RW, Weidensaul D, Allen SH, Walker SE, Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 22:2084-2091 (1995).